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Dopamine neurons in the ventral tegmental area (VTA) are implicated in affective functions. However, it is unclear to what extent
dopamine neurons in substantia nigra pars compacta (SNc) play such roles. TH-Cre transgenic mice received adeno-associated viral
vectors encoding channelrhodopsin2 (ChR2), halorhodopsin (NpHR), or control vector into the VTA or SNc, resulting in selective
expression of these opsins in dopamine neurons. Mice with ChR2 learned instrumental responding to deliver photostimulation into the
VTA or SNc and also sought for the compartment where they received photostimulation (i.e., operant place preference). Operant place
preference scores were highly correlated with self-stimulation responses. In contrast, mice with NpHR avoided the compartment where
they received photostimulation into the VTA, SNc, or dorsal striatum, whereas control mice did not. These observations suggest that
the excitation and inhibition of SNc dopamine neurons elicit positive and negative affective effects, respectively, similar to those of VTA
dopamine neurons.
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Introduction
Dopamine (DA) neurons in the ventral tegmental area (VTA) are
thought to play important roles in motivation and reward (Ike-
moto, 2007). Pharmacological studies showed that rewarding ef-
fects of many abused drugs, including psychostimulant drugs, are
mediated by DA neurons localized in the VTA projecting to the
ventral striatum and limbic cortices (i.e., the mesolimbic DA
system; Fibiger and Phillips, 1986; Koob, 1992; Robbins and
Everitt, 1996). Consistently, animals intracranially self-admini-
ster DAergic drugs into the projection regions of VTA DA neu-
rons (Ikemoto, 2007). Moreover, optogenetic studies showed
that the excitation of VTA DA neurons induces conditioned place
preference in mice (Tsai et al., 2009), and mice and rats learn
instrumental responding to excite VTA DA neurons (i.e., intra-
cranial self-stimulation, ICSS; Adamantidis et al., 2011; Witten et
al., 2011; Kim et al., 2012).
The mesolimbic DA system also plays a role in negative affect.
Conditioned place aversion is induced by injections of the D2
receptor agonist quinpirole into the VTA (Liu et al., 2008), which
inhibit activity of VTA DA neurons, or injections of D1 receptor
antagonists into the ventral striatum (Shippenberg et al., 1991).
Moreover, optogenetic inhibition of VTA DA neurons (Tan et al.,
2012) or optogenetic excitation of midbrain GABA neurons that
inhibit VTA DA neurons elicits aversion (Stamatakis and Stuber,
2012; Tan et al., 2012; Jhou et al., 2013).
The lateral counterpart to the mesolimbic DA system is the
nigrostriatal DA system, in which substantia nigra pars compacta
(SNc) DA neurons project to the dorsal striatum (DStr). This
system plays important roles in sensorimotor functions including
motor execution and habit formation (Haber, 2003). Some stud-
ies suggest affective and motivational role of this DA system
(Wise, 2009), and recent optogenetic studies begin to provide
strong evidence. Mice learn ICSS with excitation of SNc DA neu-
rons (Rossi et al., 2013) or DStr neurons expressing D1 receptors
(Kravitz et al., 2012). However, it has not yet been examined
whether inhibition of SNc DA neurons or their projections to the
DStr induces aversion. The present study compared VTA and
SNc DA neurons for their affective functions to determine the
extent to which SNc DA neurons play roles in such functions.
Materials and Methods
Adult male tyrosine hydroxylase (TH)::IRES-Cre knock-in mice (Linde-
berg et al., 2004) crossed with C57/BL/7j (weighing 24 –35 g at the time of
surgery) were used. They were individually housed in a colony main-
tained with a 12 h light/dark cycle (lights on at 07:00 A.M.), and had ad
libitum access to food and water except during testing. All procedures
were approved by the Animal Care and Use Committee of the Intramural
Research Program, National Institute on Drug Abuse and were in accor-
dance with the National Research Council Guide for the Care and Use of
Laboratory Animals.
Viral vectors. The NIDA Optogenetics and Transgenic Technology
Core produced adeno-associated virus serotype-1 (AAV) encoding
channelrhodopsin-2 (ChR2), halorhodopsin-3.0 (NpHR) and enhanced
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yellow fluorescent protein (EYFP) from plasmids obtained from the
Stanford Optogenetics Innovation Laboratory (pAAV-Ef1a-DIO-
hChR2(H134R)-EYFP-WPRE-pA, pAAV-Ef1a-DIO-eNpHR3.0-EYFP-
WPRE-pA, and pAAV-Ef1a-DIO-EYFP-WPRE-pA). The final viral
concentrations were 6.3  10 12, 1.9  10 12, and 2.3  10 12 viral-ge-
nomes/ml for ChR2, NpHR, and EYFP, respectively.
Stereotaxic surgery. Mice were anesthetized with ketamine/xylazine
mixture (80/12 mg/kg, i.p.) for stereotaxic surgeries. Injection/optic-
fiber implantation surgeries were performed unilaterally for Experi-
ments 1–3 and bilaterally for Experiment 4. The coordinates for viral
vector injections were as follows: AP 3.5 mm posteriorly from bregma,
ML 0.5 mm laterally from midline, DV 4.0 mm ventrally from the dorsal
surface of the brain for the VTA; AP 3.1, ML 1.6, DV 4.0 for the SNc; AP
0.8, ML 1.3, DV 3.0 for the medial part of DStr (mDStr); and AP 0.9,
ML 2.0, DV 2.6 for the central part of DStr (cDStr). One of the viral
vectors (Experiments 1,3: 1 l; Experiment 3: 0.2– 0.3 l; Experiment 4:
0.5 l) was microinjected by a syringe pump over 10 min into the VTA or
SNc, with additional 10 min before removal of the injection needle (33
gauge). Then, optic fibers (200 m core size with numerical aperture of
0.37), which were constructed as described previously (Sparta et al.,
2012), were chronically implanted 0.2 mm dorsal to the injection site and
secured on the skull with dental cement. Behavioral experiments were
started 1 (Experiments 1–3) or 2 (Experiment 4) months after surgery,
to allow gene expression.
Behavioral apparatus. All behavioral experiments were conducted in
standard operant conditioning chambers (Med Associates). Each cham-
ber was equipped with two levers, two cue lamps, a house lamp, an audio
stimulus generator, and four pairs of infrared detectors. Mice were gently
connected to the patch cable that was connected to either a 473 nm laser
for ChR2 or 532 nm laser for NpHR via an optical swivel. Computer
software controlled a pulse generator that controlled lasers.
ICSS test. ICSS experiments were conducted using mice that received
ChR2 or control vectors. Each session lasted for 30 min, and sessions
were typically separated by 1 d. To facilitate the acquisition of lever
pressing during the first 11 sessions, a response on the right (“active”)
lever illuminated a cue lamp for 1 s just above the lever, whereas a re-
sponse on the left (“inactive”) had no programmed consequence. In
session 12 and subsequent sessions, no cue was provided, to eliminate
possible potentiating effects of visual stimuli (Shin et al., 2010; Keller et
al., 2013). To assess baseline response levels, intracranial photostimula-
tion was not provided during the first two sessions. During sessions 3–7,
active lever pressing was rewarded with an intracranial train of 15 light
pulses (10 ms pulse duration delivered at 25 Hz) via the implanted optic
fiber. These acquisition sessions were followed by four extinction ses-
sions during which active lever pressing delivered no photostimulation.
Thereafter, four reacquisition sessions were performed with photostimu-
lation (sessions 12–17). In addition, the mice received a lever reversal test
over three sessions in which the assignment of active and inactive levers
with respect to the right and left levers was reversed in second and third
sessions without any cue. Mice used in Experiment 2 only went through
up to session 7, and in session 8, they were killed for c-Fos expression, 60
min after a 30 min ICSS session.
Operant place preference test. The test chamber described above with
levers retracted was divided into two equal size compartments by placing
a Plexiglas barrier with the height of 12 mm from the grid floor. To
further help mice to distinguish between the compartments, a 5 kHz tone
was continuously delivered when mice were in the right compartment,
while a 10 kHz tone in the left. ChR2 mouse received a 20-pulse train (10
ms pulse duration delivered at 25 Hz) in each second, whereas NpHR and
control mice received “continuous” photostimulation via the implanted
optic fiber as long as they stayed in one of the compartments. They
received photostimulation in the right compartment during the first four
sessions and in the left during the last four sessions, while keeping the
assignment of tones to the same throughout the experiment. Each session
lasted for 30 min, and sessions were typically separated by 1 d. Each
session’s place preference scores (PPSs) were derived in two ways: PPS-
right, by subtracting time spent in the left compartment from time spent
in the right compartment; and PPS-stimulation, by subtracting time
spent in nonstimulation compartment from that in stimulation com-
partment. Overall PPSs were derived by adding PPS-stimulation over
eight sessions.
Histology. After completion of the behavioral experiment, all animals
were intracardially perfused with ice-cold 0.9% saline followed by 4%
paraformaldehyde. Brains were coronally sectioned at 50 m. Some
brain sections were processed for immunohistochemistry detecting
c-Fos or colocalization of EYFP and TH. These proteins were detected by
rabbit anti-cFos (1:2000; no. AB152MI, Santa Cruz Biotechnology), goat
anti-GFP/YFP (1:1500; no. A11120, Life Technologies) and rabbit
anti-TH (1:1500; no. AB152, EMD Millipore) with goat anti-rabbit
secondary-antibody AlexaFluor 568, donkey anti-goat AlexaFluor 488
and donkey anti-rabbit AlexaFluor 594 (1:200; Life Technologies).
Mounted sections were coverslipped with DAPI nuclear counterstain
(no. H-1200, Vector Laboratories). Optical fiber placements and EYFP
expression were determined with fluorescent microscopy.
Cell-count procedures. c-Fos expression was captured with a 5 lens on
a fluorescent-microscope/video/computer system and quantified 300 
300 m areas over the SNc or VTA (Fig. 1H ) with iVision-Mac (Biovi-
sion). To determine what percentage of VTA dopamine neurons ex-
pressed ChR2 with SNc injections, we traced the VTA images
captured by a fluorescent-microscope/video/computer system with a
10 lens, identified TH- and EYFP-expressing cells with a 40 lens,
using Neurolucida (MBF Bioscience). To determine what percentage
of SNc EYFP-expressing neurons were dopaminergic, we captured
EYFP- and TH-expressing cells in the SNc with a 10 lens of the Zeiss
LSM710 confocal microscope, and the images were analyzed by Im-
ageJ (http://imagej.nih.gov/ij/).
Statistical analyses. For ANOVAs, data on lever pressing and crossing
are square-root transformed, to minimize heterogeneous variances for
parametric statistical tests (McDonald, 2009). When Mauchley’s test de-
tected violation of the sphericity assumption for repeated factors, the
degrees of freedom for respective tests were adjusted with the Green-
house–Geisser method. Significant factor effects were further analyzed
by the Tukey’s honestly significant difference post hoc test.
Results
Experiment 1: excitation of SNc DA neurons can be as
rewarding as that of VTA DA neurons
Each mouse was placed in a test chamber and given the opportu-
nity to lever press for photostimulation delivered at the SNc or
VTA over 15 sessions. We combined the data of all control mice
(n  18) during sessions 3–7, after verifying that there is no
reliable effect of stimulation region [VTA: n  12 vs SNc: n  6)
or the testing order (ICSS test first: n  7 vs operant place pref-
erence (OPP) test first: n  11] with 2group  5session ANOVAs.
Control mice responded on the active lever 39.3  5.6 (mean 
SEM) times and the inactive lever 9.8  2.0 times per session
during sessions 3–7 (Fig. 1A), and their lever press levels did not
significantly change over the course of five sessions (one-way
repeated ANOVAs). We defined that a mouse is a responder if it
responded on the active lever 3 SDs over the mean lever presses
of the control group (Fig. 1A, green dotted-line) at least in three
sessions during sessions 3–7. Seven VTA-ChR2 mice learned to
self-stimulate over 1000 times per session by session 6, decreased
responding during the extinction phase, sessions 8 –11, and rein-
stated responding during the reacquisition phase, sessions 12–15.
Two mice that were intended for VTA-ChR2 stimulation were
eliminated from the following analysis because they had probes
placed 0.5 mm or more dorsal to the VTA (Fig. 1B). Five SNc-
ChR2 mice learned vigorous ICSS, responding on the active lever
1000 times by session 6 (Fig. 1A, red dots), while responding
very little on the inactive lever (mean  SEM: 8.1  5.6 through-
out the experiment). Four SNc-ChR2 mice displayed low re-
sponse levels (Fig. 1A, orange dots). Eight SNc-ChR2 mice failed
to exceed response levels over the control range (data not shown).
These differences in response rate appear to be accounted by the
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optic fiber placement in relation to the location of ChR2-
expressing DA neurons (Fig. 1B). The placements of nonre-
sponders were generally found in regions just dorsal to the SNc or
in the lateral or posterior edges of the SNc. Thus, the response
ranges for both SNc and VTA were similarly high when the probe
placement was directly over/on the intended site. When active
and inactive lever assignment was reversed, both VTA and SNc
high-responders quickly reversed responding between the left
and right levers (Fig. 1C).
Interestingly, the VTA-ChR2 mice significantly decreased
crossing between the two halves of the chamber as they learned
ICSS (sessions 3–7 and 12–15), whereas the SNc high responders,
which showed comparable ICSS, did not (Fig. 1D; a significant
group  session interaction, F(28,182)  10.34, p  0.0001, with a
3group  15session ANOVA).
Optogenetic stimulation can excite or inhibit neurons
in a subsecond scale. We took advantage of this property to
examine affective effects of the stimulation using an OPP test
(Crowder and Hutto, 1992). It is especially difficult to de-
tect punishing effects of DA-neuron inhibition with lever
press procedures, and the conventional conditioned place-
preference test measures conditioned effects rather than im-
mediate operant reaction to stimuli. First, to determine
whether OPP can provide comparable measurement as ICSS,
some of the mice tested for ICSS (7 from the VTA group and 8
from the SNc group) were subsequently tested for OPP. Over-
all PPS were significantly correlated with active lever presses in
session 7 of the ICSS experiment (r  0.93, p  0.0001; Fig.
1E), suggesting that OPP can measure highly similar, if not the
same, affective effects as ICSS.
Figure 1. Similar rewarding effects of excitation of SNc and VTA DA neurons. A, Individual ICSS levels (active lever presses) over 15 sessions of SNc- and VTA-ChR2 mice (n  9 and 5, respectively)
and mean lever presses of control group (n  18). Green dotted line indicates 3 SDs above the mean lever presses of the control group. B, Optic-fiber placements of ChR2 mice. The tips of optic fibers
are shown by black rectangles, and just below, colored rectangles (0.3 mm in length) indicate zones most powerfully affected by photostimulation. The red, orange, and blue colors of rectangles
indicate high, low, and no responders, respectively. C, Lever presses (means  SEM; SNc: n  5, VTA: n  7) before and after reversed assignment of active and inactive levers. Rp  0.005,
right-lever values significantly greater than left-lever values in session 1 and right-lever values in sessions 2 and 3; Lp  0.005, left-lever values significantly greater than right-lever values in
corresponding sessions and left-lever values in session 1. D, Locomotor activity (means  SEM) during ICSS. *p  0.0005, VTA value significantly lower from its value of session 1, 2, or 3. E, Positive
correlation between ICSS levels in session 7 (see A) and overall PPSs of ChR2 mice (n  15). F, ICSS levels of the mice that received smaller volumes (0.2– 0.3 l) of vector injections. G, Differential
c-Fos expression between the SNc and VTA. I-SNc and I-VTA signify SNc and VTA stimulation ipsilateral to counting site; C-SNc and C-VTA signify SNc and VTA stimulation contralateral to counting
site. *p  0.05, The value significantly greater than the corresponding VTA value; #p  0.005, The value significantly greater than the corresponding SNc value and I-SNc’s VTA value. H,
Photomicrogram showing c-Fos expression following SNc stimulation. Scale bar, 300 m. IPN, Interpeduncular nucleus; ml, medial lemniscus. I, Photomicrograms showing limited colocalization
between TH and EYFP neurons within the VTA (defined by yellow line), following a SNc injection. Scale bar, 265 m. J, Colocalization of TH and EYFP in SNc neurons. Scale bar, 21 m.
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Experiment 2: specificity of
SNc photostimulation
Experiment 1 involved 1 l vector injec-
tions, and SNc injections resulted in ChR2
expression in many VTA neurons (data
not shown), raising a stimulation-speci-
ficity issue. To verify that affective effects of
SNc stimulation are indeed mediated
through SNc neurons, we examined effects
of smaller volumes of AAV-ChR2 injections
(0.2–0.3 l) into the SNc or VTA. Figure 1F
depicts lever presses of the mice that re-
ceived smaller volumes (SNc: n  5; VTA:
n  4) and displayed vigorous ICSS in ses-
sion 7. A histological analysis revealed that
the SNc-ChR2 mice had only 13.1  2.4%
(mean  SEM) of VTA TH-positive neurons
displayedEYFPexpression(Fig.1I).Figure1G
depicts c-Fos counts in the SNc and VTA fol-
lowing either SNc or VTA photostimulation.
SNc stimulation induced greater c-Fos counts
in the SNc than the VTA of the ipsilateral
hemisphere (Fig. 1H), whereas VTA stimula-
tion induced greater Fos counts in the VTA
than the SNc (a significant stimulation-
regioncounting-regioninteraction,F(1,6) 
138.89, p  0.0001, with a 2stimulation-region 
2counting-region ANOVA). Although the
mechanisms are not clear, it is interesting
to see similar, but much weaker, effects of
the stimulation on Fos counts of the con-
tralateral regions (a significant a stimula-
tion-region  counting-region interaction,
F(1,6)  11.69, p  0.05). Furthermore, a
significant stimulation-region  counting-
region  hemisphere interaction (F(1,6) 
10.49, p  0.05) was revealed with a
2stimulation-region  2counting-region  2hemisphere
ANOVA. In addition, we determined 98.8%
of ChR2 neurons are TH-positive (Pearson’s
coefficient with the JACoP of ImageJ; Fig. 1J;
Bolte and Cordelières, 2006).
Experiment 3: OPP tests reveal aversive
effects of inhibition of VTA and SNc
DA neurons
We combined the data on OPP of all con-
trol mice (n  19) after verifying that
there is no reliable effect of photostimula-
tion region (VTA: n  12 vs SNc: n  7) or
the testing order (ICSS test first: n  7 vs
OPP test first: n  12; 2group  5session
ANOVAs). Control mice, which lacked






































































































Figure 2. Aversive effects of inhibition of SNc and VTA DA neurons. Continuous photostimulation, shown in green squares, was
delivered in the right compartment during sessions 1– 4 and in the left during sessions 5– 8. A, Place avoidance as shown by
place-preference score with respect to the right compartment (PPS-R), derived by subtracting left-compartment time from right-
compartment time (means  SEM; SNc: n  7, VTA: n  10, control: n  19). *p  0.05, SNc or VTA session value significantly
different from the values in sessions 1– 4; #p  0.001, SNc or VTA values during sessions 1– 4 or 5– 6 significantly different from
respective control values. B, Locomotor activity (means  SEM) during OPP tests. C, Optic-fiber placements of SNc- and VTA-NpHR
mice. See Figure 1B legend for description. D, Place avoidance induced by inhibition of SNc-DStr DA projections. The data are
4
mean  SEM (mDStr: n  7, cDStr: n  6, control: n  5).
#p  0.05, mDStr or cDStr values during sessions 1– 4 or 5– 8
significantly different from respective control values. E, Loco-
motor activity (mean  SEM) during OPP tests. F, Optic-fiber
placements of mDStr- and cDStr-NpHR mice. See Figure 1B
legend for description. mDStr: unfilled red rectangles; cDStr:
unfilled purple rectangles.
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preference between the compartments nor did they change place
preference when stimulation compartment changed (Fig. 2A).
Both SNc and VTA NpHR mice avoided the right compartment
in sessions 1– 4 and preferred it in sessions 5– 8. These observa-
tions were confirmed by significant interactions between group
and stimulation-compartment (F(2,33)  99.00, p  0.0001) and
between group, stimulation-compartment and session (F(6,99) 
10.15, p  0.0001) with a 3group  2stimulation-compartment  4session
ANOVA. Figure 2B shows crossing counts between the two com-
partments during the OPP tests. Both SNc- and VTA-NpHR
mice crossed between the compartments less frequently than
control mice throughout the experiment (Tukey’s test following
a significant group effect: F(2,33)  11.34, p  0.0005). Figure 2C
depicts probe placements of these mice. The data of one subject
were not included for the above analyses due to probe
misplacement.
Experiment 4: OPP tests reveal aversive effects of inhibition
of nigro-striatal DA neurons
Here, we examined whether inhibition of nigro-striatal DA neu-
rons induces aversive effects. Mice received photostimulation at
the mDStr or cDStr. mDStr- and cDStr-NpHR mice (n  7 and
n  6, respectively) avoided the right compartment during ses-
sions 1– 4 and preferred it when photostimulation was delivered to
the left during sessions 5–8 (Fig. 2D). Control mice (n  5) did not
display strong preference between the two compartments through-
out the experiment. These observations are supported by significant
interactions between group and stimulation-compartment, F(2,15) 
11.36, p  0.0005, with a 3group  2stimulation-compartment  4session
ANOVA. Moreover, mDStr-NpHR mice crossed between the com-
partments less frequently than the control group (p  0.01; Fig. 2E).
A similar trend was found for cDStr-NpHR mice, although their
crossing counts were not significantly lower from those of control
(p  0.072; a significant group effect: F(2,15)  6.40, p  0.01).
Discussion
The present study provides evidence that the excitation and inhi-
bition of SNc DA neurons induce reward and aversion, respec-
tively, and the extent of these effects is similar to those of the VTA
DA neurons. The rewarding effects following SNc stimulation
appear to be mediated by direct excitation of SNc DA neurons,
because SNc-ChR2 stimulation results in large c-Fos expression
in the SNc and little expression in the VTA, whereas VTA-ChR2
stimulation does the opposite. The notion that our SNc or VTA
stimulation activated different sets of neurons is further sup-
ported by the observation that SNc- and VTA-ChR2 mice during
ICSS displayed different patterns of locomotor activity. The find-
ing that excitation of SNc DA neurons is rewarding is consistent
with the Rossi et al. (2013) study that was published while the
present study was under consideration for publication. Our data
add that stimulation of SNc DA neurons can be as rewarding as
that of VTA DA stimulation. Our finding also complements the
human research that suggests affective role of the nigro-striatal
DA system; in particular, DStr DA release is associated with crav-
ing for cocaine (Volkow et al., 2006; Wong et al., 2006). Although
research on affective effects of abused drugs has been focused on
the mesolimbic DA system, it seems to be important to further
investigate how the nigrostriatal DA system possibly participates
in affective processes involved in abused drugs.
The present study provides first evidence that inhibition of
SNc DA neurons or nigrostriatal DA projections causes aversion
like that of VTA DA neurons. Our finding has important impli-
cations in understanding Parkinson’s disease, characterized by
extensive loss of SNc DA neurons, and accompanied by not only
movement deficits, but also affective deficits including depres-
sion, anhedonia, and apathy (Chaudhuri and Schapira, 2009).
Our data raise the possibility that loss of SNc DA neurons is
sufficient to cause some of these affective deficits in Parkinson’s
patients. Consistent with this notion is that the recent report that
selective 6-OHDA lesions of SNc DA neurons attenuate escape
and avoidance from aversive stimuli (Drui et al., 2013). More-
over, in the VTA, optogenetic excitation and inhibition attenuate
and facilitate depression-like symptoms, respectively (Tye et al.,
2013). However, roles of DA neurons in affective processes may
be more complicated. Optogenetic stimulation of VTA DA neu-
rons during mild social stress potentiates subsequent induction
of depression-like behavior (Chaudhury et al., 2013). Thus, ac-
tivity of DA neurons may interact with ongoing environmental
conditions in subsequent behavior.
DA neurons of the VTA and SNc receive different afferents
(Watabe-Uchida et al., 2012) and send efferents to different re-
gions (Fallon and Moore, 1978). A recent study has shown that
even subgroups of VTA DA neurons defined by distinct afferents
and efferents play different functions (Lammel et al., 2012). Fu-
ture research needs to address how selective excitation and inhi-
bition of subgroups of DA neurons can induce similar affective
effects.
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